Stage I noninvasive and minimally invasive uterine serous carcinoma: Comprehensive staging associated with improved survival

Robert L. Giuntoli, Melissa A. Gerardi, Anna V. Yemelyanova, Stefanie M. Ueda, Aimee C. Fleury, Teresa P. Diaz-Montes, Robert E. Bristow

Research output: Contribution to journalArticle

Abstract

Objective: The aim of this study was to determine if comprehensive surgical staging is a better predictor of outcome than incomplete staging for women with stage I noninvasive or minimally invasive (≤3 mm) uterine serous carcinoma (USC). Methods: Retrospective chart review was used to identify patients undergoing hysterectomy at the Johns Hopkins Hospital from 1989 to 2010. Relevant clinical and pathologic data were extracted. Patients with noninvasive and minimally invasive (≤3-mm myometrial invasion) USC were identified. Stage was assigned based on the 2009 International Federation of Gynecology and Obstetrics endometrial cancer criteria. Survival curves were generated using the Kaplan-Meier method. Results: We identified 63 patients with noninvasive or minimally invasive (≤3 mm) USC. Stages I, II, III, and IV disease were noted in 65% (41/63), 6% (4/63), 14% (9/63), and 14% (9/63) of the patients, respectively. Lower stage was associated with a significantly improved disease-specific survival (P = 0.001). Comprehensive staging, including total hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, omentectomy, and peritoneal biopsies, was completed in 29% (12/41) of the patients with stage I disease. There were no disease-specific deaths in the comprehensive staging group. Compared with incomplete staging, comprehensive staging was associated with a significantly improved disease-specific survival (P = 0.039). Conclusions: Patients with stage I noninvasive and minimally invasive USC on comprehensive staging have an excellent prognosis. Adjuvant therapy may not benefit this patient population.

Original languageEnglish (US)
Pages (from-to)273-279
Number of pages7
JournalInternational Journal of Gynecological Cancer
Volume22
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Carcinoma
Survival
Hysterectomy
Ovariectomy
Endometrial Neoplasms
Lymph Node Excision
Gynecology
Obstetrics
Biopsy
Population
Therapeutics

Keywords

  • Adjuvant therapy
  • Surgical staging
  • Uterine serous carcinoma

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Giuntoli, R. L., Gerardi, M. A., Yemelyanova, A. V., Ueda, S. M., Fleury, A. C., Diaz-Montes, T. P., & Bristow, R. E. (2012). Stage I noninvasive and minimally invasive uterine serous carcinoma: Comprehensive staging associated with improved survival. International Journal of Gynecological Cancer, 22(2), 273-279. https://doi.org/10.1097/IGC.0b013e318238df4d

Stage I noninvasive and minimally invasive uterine serous carcinoma : Comprehensive staging associated with improved survival. / Giuntoli, Robert L.; Gerardi, Melissa A.; Yemelyanova, Anna V.; Ueda, Stefanie M.; Fleury, Aimee C.; Diaz-Montes, Teresa P.; Bristow, Robert E.

In: International Journal of Gynecological Cancer, Vol. 22, No. 2, 02.2012, p. 273-279.

Research output: Contribution to journalArticle

Giuntoli, Robert L. ; Gerardi, Melissa A. ; Yemelyanova, Anna V. ; Ueda, Stefanie M. ; Fleury, Aimee C. ; Diaz-Montes, Teresa P. ; Bristow, Robert E. / Stage I noninvasive and minimally invasive uterine serous carcinoma : Comprehensive staging associated with improved survival. In: International Journal of Gynecological Cancer. 2012 ; Vol. 22, No. 2. pp. 273-279.
@article{96179bf3370d49bd93906f2dc43b47b4,
title = "Stage I noninvasive and minimally invasive uterine serous carcinoma: Comprehensive staging associated with improved survival",
abstract = "Objective: The aim of this study was to determine if comprehensive surgical staging is a better predictor of outcome than incomplete staging for women with stage I noninvasive or minimally invasive (≤3 mm) uterine serous carcinoma (USC). Methods: Retrospective chart review was used to identify patients undergoing hysterectomy at the Johns Hopkins Hospital from 1989 to 2010. Relevant clinical and pathologic data were extracted. Patients with noninvasive and minimally invasive (≤3-mm myometrial invasion) USC were identified. Stage was assigned based on the 2009 International Federation of Gynecology and Obstetrics endometrial cancer criteria. Survival curves were generated using the Kaplan-Meier method. Results: We identified 63 patients with noninvasive or minimally invasive (≤3 mm) USC. Stages I, II, III, and IV disease were noted in 65{\%} (41/63), 6{\%} (4/63), 14{\%} (9/63), and 14{\%} (9/63) of the patients, respectively. Lower stage was associated with a significantly improved disease-specific survival (P = 0.001). Comprehensive staging, including total hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, omentectomy, and peritoneal biopsies, was completed in 29{\%} (12/41) of the patients with stage I disease. There were no disease-specific deaths in the comprehensive staging group. Compared with incomplete staging, comprehensive staging was associated with a significantly improved disease-specific survival (P = 0.039). Conclusions: Patients with stage I noninvasive and minimally invasive USC on comprehensive staging have an excellent prognosis. Adjuvant therapy may not benefit this patient population.",
keywords = "Adjuvant therapy, Surgical staging, Uterine serous carcinoma",
author = "Giuntoli, {Robert L.} and Gerardi, {Melissa A.} and Yemelyanova, {Anna V.} and Ueda, {Stefanie M.} and Fleury, {Aimee C.} and Diaz-Montes, {Teresa P.} and Bristow, {Robert E.}",
year = "2012",
month = "2",
doi = "10.1097/IGC.0b013e318238df4d",
language = "English (US)",
volume = "22",
pages = "273--279",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Stage I noninvasive and minimally invasive uterine serous carcinoma

T2 - Comprehensive staging associated with improved survival

AU - Giuntoli, Robert L.

AU - Gerardi, Melissa A.

AU - Yemelyanova, Anna V.

AU - Ueda, Stefanie M.

AU - Fleury, Aimee C.

AU - Diaz-Montes, Teresa P.

AU - Bristow, Robert E.

PY - 2012/2

Y1 - 2012/2

N2 - Objective: The aim of this study was to determine if comprehensive surgical staging is a better predictor of outcome than incomplete staging for women with stage I noninvasive or minimally invasive (≤3 mm) uterine serous carcinoma (USC). Methods: Retrospective chart review was used to identify patients undergoing hysterectomy at the Johns Hopkins Hospital from 1989 to 2010. Relevant clinical and pathologic data were extracted. Patients with noninvasive and minimally invasive (≤3-mm myometrial invasion) USC were identified. Stage was assigned based on the 2009 International Federation of Gynecology and Obstetrics endometrial cancer criteria. Survival curves were generated using the Kaplan-Meier method. Results: We identified 63 patients with noninvasive or minimally invasive (≤3 mm) USC. Stages I, II, III, and IV disease were noted in 65% (41/63), 6% (4/63), 14% (9/63), and 14% (9/63) of the patients, respectively. Lower stage was associated with a significantly improved disease-specific survival (P = 0.001). Comprehensive staging, including total hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, omentectomy, and peritoneal biopsies, was completed in 29% (12/41) of the patients with stage I disease. There were no disease-specific deaths in the comprehensive staging group. Compared with incomplete staging, comprehensive staging was associated with a significantly improved disease-specific survival (P = 0.039). Conclusions: Patients with stage I noninvasive and minimally invasive USC on comprehensive staging have an excellent prognosis. Adjuvant therapy may not benefit this patient population.

AB - Objective: The aim of this study was to determine if comprehensive surgical staging is a better predictor of outcome than incomplete staging for women with stage I noninvasive or minimally invasive (≤3 mm) uterine serous carcinoma (USC). Methods: Retrospective chart review was used to identify patients undergoing hysterectomy at the Johns Hopkins Hospital from 1989 to 2010. Relevant clinical and pathologic data were extracted. Patients with noninvasive and minimally invasive (≤3-mm myometrial invasion) USC were identified. Stage was assigned based on the 2009 International Federation of Gynecology and Obstetrics endometrial cancer criteria. Survival curves were generated using the Kaplan-Meier method. Results: We identified 63 patients with noninvasive or minimally invasive (≤3 mm) USC. Stages I, II, III, and IV disease were noted in 65% (41/63), 6% (4/63), 14% (9/63), and 14% (9/63) of the patients, respectively. Lower stage was associated with a significantly improved disease-specific survival (P = 0.001). Comprehensive staging, including total hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, omentectomy, and peritoneal biopsies, was completed in 29% (12/41) of the patients with stage I disease. There were no disease-specific deaths in the comprehensive staging group. Compared with incomplete staging, comprehensive staging was associated with a significantly improved disease-specific survival (P = 0.039). Conclusions: Patients with stage I noninvasive and minimally invasive USC on comprehensive staging have an excellent prognosis. Adjuvant therapy may not benefit this patient population.

KW - Adjuvant therapy

KW - Surgical staging

KW - Uterine serous carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84858223964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858223964&partnerID=8YFLogxK

U2 - 10.1097/IGC.0b013e318238df4d

DO - 10.1097/IGC.0b013e318238df4d

M3 - Article

C2 - 22146771

AN - SCOPUS:84858223964

VL - 22

SP - 273

EP - 279

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 2

ER -